Xi Chen Lin
Fortuna: 4 M $ al 30/06/2026
Fortuna: 4 M $ al 30/06/2026
Dr. Xi Chen Lin is a Chief Scientific Officer & GM-Structure Shanghai at Structure Therapeutics, Inc. and a General Manager at Shanghai ShouTi Biotechnology Co. Ltd. Dr. Lin was previously employed as a Head-Asia Pacific External Innovation by Novo Nordisk A/S.
He received his undergraduate degree from Peking University and a doctorate degree from The Pennsylvania State University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 04/08/2026 | 228.960 ( 0,16 % ) | 4 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| STRUCTURE THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/07/2019 |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/07/2019 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Structure Therapeutics, Inc.
Structure Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops molecule therapeutics to treat chronic diseases | Health Technology |
Shanghai ShouTi Biotechnology Co., Ltd.
Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.